Greylin Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Greylin Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$966K	Buy
2023 Q1	–	Sell
2022 Q4	$222K	Sell
2022 Q3	$277K	Sell
2022 Q2	$653K	Sell
2022 Q1	$676K	Buy
2021 Q4	$445K	Buy
2021 Q3	$292K	Buy
2021 Q2	$247K	Buy